| [1] |
ZHANG Shiyi, SUN Jiamin, ZHONG Jianhong, WANG Qiuyan, TAO Yuting.
Clinical significance of YAP signaling activation in extracellular matrix remodeling in hepatocellular carcinoma and its molecular mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 30-39.
|
| [2] |
LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei.
Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
|
| [3] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
| [4] |
WANG Huimin, ZHAO Dongming, LI Xianfeng.
Research progress on multifunctional nano-drug delivery system in the treatment of liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 128-132.
|
| [5] |
LIN Leipo, HUANG Zhihao, XIANG Bangde, MA Liang, LI Lequn, ZHONG Jianhong .
Interpretation of 2024 ACG Clinical Guideline: Focal Liver Lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 656-662.
|
| [6] |
JIANG Yuan, WANG Xiaoyan, LEI lei, LIU Lihua, WU Danfeng, ZHANG Siqi, TANG Dairong, FAN Lingli, FENG Gang, XUE Xiaojing.
Summary of the best evidence for blood glucose management in cancer patients with immune checkpoint inhibitors inducing hyperglycemia
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 722-728.
|
| [7] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
| [8] |
WANG Jinming, LI Yaojie, QIU Guogao, LIU Shaoping, LIU Jie, YOU Xuemei, MA Liang, ZHONG Jianhong.
ESMO 2024: new breakthroughs and future trends in hepatocellular carcinoma treatment
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 741-746.
|
| [9] |
WANG Xingchen, LIAO Dawen, LI Jiaying, SUN Xiacheng, BI Qian, Huang Qichao, HUANG Jiangtao.
Comparative analysis of molecular characteristics of constitutive activation of NRAS and CTNNB1 in liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 577-585.
|
| [10] |
TANG Min, HUANG Juanchan, WEI Xingwen, LUO Xuewen, ZHAO Wei .
Effects of disulfiram combined with Cu2+ induced cuproptosis on proli-feration,migration and invasion of hepatoma Hep3B cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 417-423.
|
| [11] |
LIANG Si, SHENG Yonghong, LIU Shun, LIU Meiliang, YANG Yu, LEI Lei, WU Lili, ZENG Xiaoyun.
Gene expression profiling of peripheral blood B cells before and after surgery for hepatocellular carcinoma based on single-cell RNA sequencing technology
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 433-.
|
| [12] |
ZHANG Siyi, HUANG Xiangyang, QIN Yunying, LIU Lijuan, HUANG Caiyun, LUO Ningbin.
Preoperative CT signs combined with clinical indicators predict the expression of cytokeratin 19 in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 461-467.
|
| [13] |
LU Feichen, YOU Xuemei, ZHAO Fengjuan, LI Fanrong, WEI Shuangshuang, YANG Lijie.
Investigation on the status quo of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 468-473.
|
| [14] |
LI Huadao, LIN Liqiao, LIANG Yubing, HUANG Enhao, PAN Linghui.
Effects of Herba Houttuyniae on the biological behavior of liver cancer cells and a network pharmacology analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 277-284.
|
| [15] |
WANG Guanyu, PAN Lixin, WANG Jiandong, WANG Qiuyan, TAO Yuting .
An analysis of the effect of hypoxia on the tumor microenvironment of hepatocellular carcinoma based on transcriptomics and proteomics techniques
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 308-316.
|
